Manage stand orders
Select Option
Advertisement
BIOCLARMA SRL
Via Nizza, 52,
10126
Torino
Italy
Italy
This company is co-exhibitor of
CEIPIEMONTE S.C.p.A. / PIEMONTE AGENCY
Location
Hall map
Fairground map
Our range of products
Product categories
- 03 Diagnostic Tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.04 Other molecular diagnostics testing
Other molecular diagnostics testing
Our products
Product category: Other molecular diagnostics testing
Gene Specific FISH Probes
Gene Specific probes are designed to hybridize to a precise gene location. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads. Gene specific probes are available in both single and dual colors. ASR and CE marked gene specific probes are available.
Product category: Other molecular diagnostics testing
Acute Lymphoblastic Leukemia FISH Probes
The following Fluorescence In Situ Hybridization (FISH) probes can be used use to identify aberrations of genes clinically relevant to Acute Lymphoblastic Leukemia. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads. These probes are available in both single and dual colors. ASR and CE marked gene specific probes are available.
About us
Company details
Empire Genomics designs, manufactures and distributes more than one million clinical and custom labeled molecular probes, enabling hundreds of leading global clinical laboratories, biotechnology organizations and academic institutions to advance biomarker research, accelerate diagnoses and improve personalized treatment options for patients battling cancer and other complex diseases. The company was founded in 2006 by Norma J. Nowak, PhD, a prominent member of the Human Genome Project, to utilize innovative research started at the prestigious Roswell Park Cancer Institute in Buffalo, New York. The comprehensive product portfolio includes Fluorescence in Situ Hybridization (FISH) and Chromogenic in Situ Hybridization (CISH) probes that are designed and optimized for specific diseases, genes, and/or regions across the entire human or mouse genomes.